As of January 22, 2025, Janux Therapeutics (JANX) has a market cap of $2.37 billion USD. According to our data, Janux Therapeutics is ranked No.3867 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $2.37 B |
-24.53%
|
Dec 31, 2024 | $3.14 B |
398.97%
|
Dec 29, 2023 | $0.63 B |
-18.53%
|
Dec 30, 2022 | $0.77 B |
-33.25%
|
Dec 31, 2021 | $1.16 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Fate Therapeutics
FATE
|
$0.15 B |
-0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.78 B |
-0.017 B
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.14 B |
0.000 M
|
UK
|
Atara Biotherapeutics
ATRA
|
$35.25 M |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.628 M
|
France
|
Autolus Therapeutics
AUTL
|
$0.56 B |
0.000 M
|
UK
|
Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
Precision BioSciences
DTIL
|
$36.21 M |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.82 B |
6.828 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.10 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.03 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.02 M |
0.000 M
|
USA
|
Market Cap | = | JANX Stock Price | * | JANX Shares Outstanding |
= | $40.40 | * | 58.63 M | |
= | $2.37 B |